NeuroPace Raises FY2026 Sales Guidance from $98.000M-$100.000M to $99.000M-$101.000M vs $98.910M Est

Benzinga Newsdesk www.benzinga.com Positive 93.3%

Neg 0% Neu 0% Pos 93.3%

NeuroPace (NASDAQ:NPCE) raises FY2026 sales outlook from $98.000 million-$100.000 million to $99.000 million-$101.000 million vs $98.910 million estimate.